Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Atherosclerosis. 2016 Sep 22;254:59–66. doi: 10.1016/j.atherosclerosis.2016.09.017

Fig. 1. Experimental design.

Fig. 1

Twenty-three patients were divided into three groups: Healthy controls (n=7), untreated (n=8), and CPAP-treated (n=8). OSA control or CPAP-treated patients were monitored before and after 3 months after treatment, and further subdivided into the following groups: pre-Untreated, post-Untreated, pre-CPAP, and post-CPAP.